Skip to main content
Download PDF
Download ePub

Volume 15 Supplement 1

Abstracts from the 4th European Headache and Migraine Trust International Congress: EHMTIC 2014

  • Meeting abstract
  • Open access
  • Published:

EHMTI-0377. The influence of genetic constitution on migraine drug responses

The Journal of Headache and Pain volume 15, Article number: M3 (2014) Cite this article

Background

Specific acute treatments of migraine are 5HT1B/D receptor agonists, i.e. triptans and ergotamine. No migraine prophylactic drugs are specific to migraine. Prophylactic drugs are selected by time consuming “trial and error”. Personalized treatment is therefore much needed.

Aim

The objective of this study was to test the effect of 12 common SNPs significantly associated with migraine on migraine drug responses.

Methods

Semi-structured migraine interviews, blood samples and genotyping were performed on 1806 unrelated migraine cases recruited from the Danish Headache Center. Association analyses were carried out using logistic regression and ORs were calculated assuming an additive model for risk. The effect on drug responses was tested for a combined genetic score and for each of the 12 SNPs.

Results

A higher combined genetic score, and a single SNP, rs2651899 in PRDM16, were significantly associated with efficacy of triptans with an OR of success of 2.6 and 1.3, respectively. A number of SNPs showed nominal preferential association with the efficacy of triptans and others with prophylactic drugs.

Conclusion

We show for the first time an association between genetic constitution and migraine drug response. This is a first step towards future individualized medicine.

No conflict of interest.

Author information

Authors and Affiliations

  1. Dep. of Neurology Glostrup University Hospital University of Copenhagen, Danish Headache Center, Copenhagen, Denmark

    AF Christensen, AL Esserlind & J Olesen

  2. Institute of Biological Psychiatry, Mental Health Center Sct. Hans University of Copenhagen, Roskilde, Denmark

    T Werge

  3. deCODE Genetics, Sturlugata 8, Reykjavik, Iceland

    H Stefansson

Authors
  1. AF Christensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. AL Esserlind
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Werge
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Stefansson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Olesen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Christensen, A., Esserlind, A., Werge, T. et al. EHMTI-0377. The influence of genetic constitution on migraine drug responses. J Headache Pain 15 (Suppl 1), M3 (2014). https://doi.org/10.1186/1129-2377-15-S1-M3

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1129-2377-15-S1-M3

Keywords

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us